Australia's largest stock trading and investment forum Australia's #1 stock forum

KZA

Click for more information

0.00%

8.0¢ kazia therapeutics limited

Latest interview, page-7

First 7 Last

Share
Profile

Follow
Sherpa1

67 Posts.

95

06/05/22

02:51

Post #: 61239544
Share

Originally posted by Rich&Poor: ↑

Thank you, Rinnekin for posting the Pro active investor interview video.
James has his mojo back with discussion on the release dates of paxalisib trials both interim and final data next month.
He discusses demand from the US sophisticated investors for ADS's - At The Market (ATM) share cash equity issuing facility eloquently, using examples of possible liquidity demand for ADS's - ATM when the KZIA share price is maybe double or triple in value, which could be triggered by new regional drug licence agreements, (similar to the Simcere China licence)
Possible new paxalisib trial next year for rare childhood cancer AT/RT
DIPG - PNOC study recruiting like wildfire with possibility of registration approval with a valuable rare childhood disease voucher attached.
GBM AGILE phase 3 registration data available - 2H CY2023.
And the list goes on and on.

Regards.

Expand

James has his mojo back

He never lost his mojo.
Others lost their patience.

KZA Price at posting: 80.0¢ Sentiment: Buy Disclosure: Held
8 Upvote

3 Great analysis

Reply

Top Stories

WGX

Australian foreign investment regulators greenlight Westgold's buyout of Karora

ASX Market Open: ASX200 set for -0.75% fall after NASDAQ hammered | July 18 2024

SKC

SkyCity to lose NZ$5M in 2025 over complaint closedown

AI stocks: What to expect in 2024-25

M2R

Miramar sniffs 5.48% Cu, 54.4% Pb and 73.48g/t Ag at new WA prospect

There are more pages in this discussion • 65 more messages in this thread...

First 7 Last

Add KZA (ASX) to my watchlist